Actinogen Medical Ltd
ACW•Health Care•Biotechnology•Last updated: Dec 25
About
Actinogen Medical Ltd is a biotechnology company focused on the development of innovative treatments for cognitive impairment associated with neurological diseases. The company's lead product, Xanamem, is designed to inhibit the production of cortisol in the brain, which is believed to play a role in cognitive decline. Actinogen's operations are primarily centered around clinical trials and research and development activities.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- ACW
Related Shares
Investor Resources
Should you buy Actinogen Medical Ltd right now?
While ACW looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now